Aeterna Zentaris (AEZS) Reports Results from Phase 3 Trial for Perifosine; Data Showed No Benefit in Survival

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/3/2026

1. AMZN
2. RBLX
3. AAPL
4. RDDT
5. COIN
6. NBIX
7. DXCM
8. GH
9. GDDY
10. WU

Go back to Aeterna Zentaris (AEZS) Reports Results from Phase 3 Trial for Perifosine; Data Showed No Benefit in Survival